Evidence map›Paper›PMID 28124569›Full record

Trial reportThe British journal of radiology2017

A comparison of imaging guided double percutaneous aspiration injection and surgery in the treatment of cystic echinococcosis of liver.

Tahleel A Shera, Naseer A Choh, Tariq A Gojwari, Faiz A Shera, Feroze A Shaheen, Ghulam M Wani, Irfan Robbani, Nisar A Chowdri, Altaf H Shah

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The British journal of radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Treatment of uncomplicated hepatic cystic echinococcosis (hydatid disease).The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. PercutaneousWorld journal of gastroenterology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Results of multimodal treatment of hepatic echinococcosis].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tahleel A Shera1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Naseer A Choh1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Tariq A Gojwari1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Faiz A Shera1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Feroze A Shaheen1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Ghulam M Wani1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Irfan Robbani1 Department of Radiodiagnosis and Imaging, SKIMS, Srinagar, India.
Nisar A Chowdri2 Department of General Surgery, SKIMS, Srinagar, India.
Altaf H Shah3 Department of Gastroentrology, SKIMS, Srinagar, India.
Sher-i-Kashmir Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare the results and complications of treatment by double percutaneous aspiration injection (DPAI) in cystic echinococcosis (CE) of the liver with those of surgery. To the best of our knowledge, such a study has not been carried out till date.

methodsFrom November 2012 to November 2015, 43 patients were randomly allocated to DPAI group (n = 22) and surgery group (n = 21). After the intervention, patients were evaluated monthly for 3 months, then at the sixth month and 6 monthly thereafter.

resultsAverage hospital stay was 2.38 days in DPAI group and 8.23 days in the surgery group. Response to DPAI was categorized as successful in 95.3% (n = 20) patients and incomplete in 4.7% (n = 1) patients. Response to surgery was characterized as successful in 85.7% (n = 18) patients and incomplete in 4.7% (n = 1) patients, and recurrence was seen in 9.5% (n = 2) patients. Using a 10% margin for non-inferiority, treatment response in the DPAI group was non-inferior to that of the surgery group. In the DPAI group, 19 patients had no complications, minor complications were seen in 4.7% (n = 1) patients and a major complication was seen in 4.7% (n = 1) patients. In the surgery group, no complications were seen in 13 patients, major complications were seen in 28.57% (n = 6) patients and minor complications were seen in 9.5% (n = 2) patients.

conclusionOver a follow-up period of 3 years, DPAI is non-inferior to surgery in the treatment of CE of the liver, while there is a statistically significant difference in the hospital stay and occurrence of complications. Advances in knowledge: DPAI offers advantages such as a short hospital stay, minimal invasiveness and morbidity, while being non-inferior to surgery. Total Immunoglobulin G antibody titres have limited utility in follow-up of patients treated.

Indexed as

Ultrasonography, InterventionalAdultEchinococcosis, HepaticFemaleFollow-Up StudiesHumansInjections, IntralesionalLength of StayLiverMaleProspective StudiesRecurrenceSuctionTreatment Outcome

Identifiers

PMID28124569
PMCPMC5605063
OpenAlexW2581759856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.